Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVernalis PLC Regulatory News (VER)

  • There is currently no data for VER

AGM Statement

26 Jun 2008 10:56

RNS Number : 5560X
Vernalis PLC
26 June 2008
Β 

ο»Ώ

26 June 2008

VERNALIS PLC

RESULTS OF THE ANNUAL GENERAL MEETING HELD ONΒ 26 JUNE 2008

Vernalis plc announces that all resolutions proposed to shareholders at its Annual General Meeting held today were duly passed.

All resolutions were approved on a show of hands. The number of proxy votes received for each resolution is set out below.

Resolution

For (including discretionary votes)*

Against*

Withheld

Ordinary Resolution

1. To receive the audited accounts and related reports of the Directors and auditors

179,202,997

(99.99%)

11,877

(0.01%)

7,930

2. To approve the remuneration report

175,655,235

(98.02%)

3,548,448

(1.98%)

19,121

3. To re-elect as a Director Dr P R Read

178,780,069

(99.76%)

424,802

(0.24%)

17,933

4. To re-elect as a Director Mr G M Kennedy

178,776,979

(99.76%)

427,642

(0.24%)

18,183

5. To re-appoint PricewaterhouseCoopers LLP as auditors and to authorise the Directors to determine their remunerationΒ 

178,807,909

(99.78%)

403,223

(0.22%)

11,672

6. To authorise the Directors to allot relevant securitiesΒ 

179,152,472

(99.98%)

30,266

(0.02%)

40,066

Special Resolution

7. To authorise the Directors to allot equity securities for cash

179,147,026

(99.98%)

35,436

(0.02%)

40,342

OrdinaryΒ Resolution

8. To permit electronic communications

179,093,365

(99.97%)

51,968

(0.03%)

77,471

SpecialΒ Resolution

9. To adopt new articlesΒ with effect from 1st October 2008

179,165,441

(99.98%)

33,105

(0.02%)

13,106

*NB: Percentage of votes cast excludes withheld votes

Enquiries:

Vernalis plc +44 (0)118 977 3133

Tony Weir, Chief Financial Officer

Brunswick Group +44 (0)20 7404 5959

Jon Coles

Alex Tweed

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
RAGQELFLVQBFBBK
Date   Source Headline
28th Apr 20177:00 amRNSTotal Voting Rights
26th Apr 20177:00 amRNSServier and Vernalis announce 3 milestones
21st Apr 20177:01 amRNSVernalis receives $2 million milestone payment
21st Apr 20177:00 amRNSFDA Issues Complete Response Letter on CCP-07 NDA
29th Mar 20179:00 amRNSBlock listing Interim Review
6th Mar 20177:00 amRNSNew drug discovery collaboration with Servier
28th Feb 20177:00 amRNSTotal Voting Rights
21st Feb 20177:00 amRNSUnaudited interim results for 6 months to 31/12/16
14th Feb 20177:00 amRNSAchievement of a $3m milestone payment from Corvus
30th Jan 201712:36 pmRNSNotice of Results for Six Months Ended 31/12/2016
21st Dec 20167:00 amRNSFDA accepts CCP-08 NDA for full review
1st Dec 20161:00 pmRNSVernalis Results of Annual General Meeting
1st Dec 20167:00 amRNSAGM Statement
3rd Nov 20164:36 pmRNSHolding(s) in Company
31st Oct 20167:00 amRNSTotal Voting Rights
24th Oct 20169:43 amRNSNotice of Annual Report and AGM
13th Oct 201611:58 amRNSHolding(s) in Company
12th Oct 20164:58 pmRNSDirector/PDMR Shareholding
12th Oct 20164:57 pmRNSDirector/PDMR Shareholding
5th Oct 20162:00 pmRNSHolding(s) in Company
5th Oct 20161:02 pmRNSHolding(s) in Company
30th Sep 20163:55 pmRNSDirector/PDMR Shareholding
29th Sep 20163:00 pmRNSBlock listing Interim Review
29th Sep 20167:00 amRNSResults Announcement for 12 months ended 30/06/16
22nd Sep 20161:43 pmRNSHolding(s) in Company
14th Sep 201610:54 amRNSHolding(s) in Company
13th Sep 201610:34 amRNSNotice of Results
6th Sep 20167:00 amRNSFDA accepts CCP-07 NDA for full review
29th Jul 20167:00 amRNSTotal Voting Rights
26th Jul 201612:53 pmRNSHolding(s) in Company
19th Jul 20167:00 amRNSVernalis Achieves Oncology Milestone with Servier
15th Jul 20167:00 amRNSVernalis Notes RedoxTherapies Acquisition by Juno
8th Jul 20167:00 amRNSVernalis Announce CCP-08 Multiple-Dose Results
7th Jul 20161:47 pmRNSYear-end Trading Update and Notice of Results
30th Jun 20167:00 amRNSTotal Voting Rights
24th Jun 20163:52 pmRNSHolding(s) in Company
9th Jun 20162:58 pmRNSDirector Dealing
31st May 20167:00 amRNSTotal Voting Rights
19th May 20164:11 pmRNSMoxatag Supply Update
16th May 20162:44 pmRNSHolding(s) in Company
12th May 201611:10 amRNSResults of General Meeting
29th Apr 20167:00 amRNSTotal Voting Rights
27th Apr 20164:40 pmRNSHolding(s) in Company
26th Apr 20165:17 pmRNSPosting of Circular and Notice of General Meeting
26th Apr 201611:00 amRNSVernalis plc to raise £40 million in Placing
21st Apr 20162:26 pmRNSSandford Sommer appointed as President & COO in US
14th Apr 20167:00 amRNSVernalis Announce CCP-07 Multiple-Dose Results
13th Apr 20167:00 amRNSVernalis Announce CCP-08 Single-Dose Study Results
31st Mar 20169:00 amRNSTotal Voting Rights
29th Mar 20161:55 pmRNSBlocklisting Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.